======= ZMYND11 =======
== Gene Information ==
* **Official Symbol**: ZMYND11
* **Official Name**: zinc finger MYND-type containing 11
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=10771|10771]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q15326|Q15326]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=ZMYND11&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ZMYND11|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/608668|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: The protein encoded by this gene was first identified by its ability to bind the adenovirus E1A protein. The protein localizes to the nucleus. It functions as a transcriptional repressor, and expression of E1A inhibits this repression. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008].
* **UniProt Summary**: Chromatin reader that specifically recognizes and binds histone H3.3 trimethylated at 'Lys-36' (H3.3K36me3) and regulates RNA polymerase II elongation. Does not bind other histone H3 subtypes (H3.1 or H3.2) (By similarity). Colocalizes with highly expressed genes and functions as a transcription corepressor by modulating RNA polymerase II at the elongation stage. Binds non- specifically to dsDNA (PubMed:24675531). Acts as a tumor- suppressor by repressing a transcriptional program essential for tumor cell growth. {ECO:0000250|UniProtKB:Q8R5C8, ECO:0000269|PubMed:10734313, ECO:0000269|PubMed:16565076, ECO:0000269|PubMed:24675531}.
|PWWP|
|Bromodomain|
|regulation of transcription elongation from RNA polymerase II promoter|
|negative regulation of JNK cascade|
|negative regulation of I-kappaB kinase/NF-kappaB signaling|
|negative regulation of stress-activated protein kinase signaling cascade|
|negative regulation of stress-activated MAPK cascade|
|regulation of DNA-templated transcription, elongation|
|methylated histone binding|
|negative regulation of extrinsic apoptotic signaling pathway|
|double-stranded DNA binding|
|chromosome|
|regulation of extrinsic apoptotic signaling pathway|
|negative regulation of MAPK cascade|
|regulation of JNK cascade|
|defense response to virus|
|negative regulation of apoptotic signaling pathway|
|regulation of stress-activated MAPK cascade|
|regulation of I-kappaB kinase/NF-kappaB signaling|
|regulation of stress-activated protein kinase signaling cascade|
|transcription corepressor activity|
|response to virus|
|regulation of apoptotic signaling pathway|
|negative regulation of protein phosphorylation|
|negative regulation of phosphorylation|
|negative regulation of intracellular signal transduction|
|negative regulation of phosphate metabolic process|
|negative regulation of phosphorus metabolic process|
|negative regulation of protein modification process|
|chromatin organization|
|viral process|
|regulation of cellular response to stress|
|regulation of MAPK cascade|
|symbiotic process|
|interspecies interaction between organisms|
|zinc ion binding|
|negative regulation of apoptotic process|
|negative regulation of programmed cell death|
|defense response to other organism|
|negative regulation of cell death|
|negative regulation of cellular protein metabolic process|
|chromosome organization|
|immune effector process|
|negative regulation of protein metabolic process|
|negative regulation of transcription, DNA-templated|
|negative regulation of nucleic acid-templated transcription|
|negative regulation of RNA biosynthetic process|
|negative regulation of signal transduction|
|response to other organism|
|response to external biotic stimulus|
|response to biotic stimulus|
|negative regulation of RNA metabolic process|
|defense response|
|cell cycle|
|negative regulation of cell communication|
|negative regulation of signaling|
|negative regulation of cellular macromolecule biosynthetic process|
|negative regulation of nucleobase-containing compound metabolic process|
|regulation of protein phosphorylation|
|negative regulation of macromolecule biosynthetic process|
|regulation of response to stress|
|negative regulation of cellular biosynthetic process|
|regulation of apoptotic process|
|negative regulation of biosynthetic process|
|regulation of programmed cell death|
|regulation of phosphorylation|
|negative regulation of response to stimulus|
|regulation of cell death|
|negative regulation of gene expression|
|regulation of phosphate metabolic process|
|regulation of phosphorus metabolic process|
|regulation of intracellular signal transduction|
|regulation of protein modification process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp468|CB-5083 0.4μM R08 exp468]]|1.73|
|[[:results:exp103|Taxol 0.004μM R03 exp103]]|1.75|
|[[:results:exp116|AICAR 240μM R03 exp116]]|1.77|
|[[:results:exp310|2-Methoxyestradiol 0.55μM R07 exp310]]|1.78|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/726
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/25|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/15|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/14|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/7|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 11160
* **Expression level (log2 read counts)**: 6.15
{{:chemogenomics:nalm6 dist.png?nolink |}}